NO MORE INJECTIONS,ROBOTIC PILL WILL DELIVER MEDICINES IN BODY

NO MORE INJECTIONS,ROBOTIC PILL WILL DELIVER MEDICINES IN BODY

PROF .DRRAM,HIV /AIDS,HEPATITIS ,SEX DISEASES & WEAKNESS expert,New Delhi,India, profdrram@gmail.com,+917838059592,+919832025033,ON WHATSAPP

Injectios are painful but an important method of administering medicines in body either subcutaneous,dermal,IM, IV, intra peritoneal,pleural and intrathecal route etc.but now days are coming when Robotic pills will be used for such delivery of medicines in body.

    Tiny devices like Robotic Pills may soon perform surgery, administer drugs and help in diagnosing numerous diseases. The notion of coming up with robotic pill in screening, diagnosis and therapeutic procedures seemed to be a novel biotechnology and engineering challenge in the past. The day is not far enough when doctors will start recommending patients to swallow sophisticated gadgets instead of taking pills or injections. With this idea in mind, Mir Imran has developed a robotic pill to replace inject-able drugs for chronic conditions like diabetes.This research is backed by Google Inc's venture-capital unit.
This pill consists of an ingestible polymer and tiny hollow needles made of sugar that are designed to safely deliver drugs to the small intestine.

       This pill is developed by an Indian-born, founder of research lab and business incubator, Incube Labs in Silicon Valley. He is the founder of more than 20 medical-device start-ups. More than dozens of such start- ups have been acquired by companies such as Medtronic Inc. He is the developer of first implantable cardiometer defibrillator to correct irregular heartbeats. Also it has come to light that the pharma companies which would license the technology for use with their own drugs have already started showing interest in this research project.

The pre-clinical studies it is proved that this pill can boost drug absorption as high as syringes do. this pill has not been tested on humans , it is probably a year away from getting federal approval. But once this research is approved it has immense potential to rupture existing multi-billion dollar market for injectable drugs. This will benefit doctors as well as patients suffering from diseases like diabetes and rheumatoid arthritis. This research has vast scope in various fields and it is the need of time.